To quantify the changes of hemoglobin mass (Hb mass ) and maximum oxygen consumption (VO 2max ) after 22 days training at 1300-1800 m combined with nightly exposure to 3000-m simulated altitude. We hypothesized that with simulated 3000-m altitude, an adequate beneficial dose could be as little as 10 h/24 h. Methods: Fourteen male collegiate runners were equally divided into 2 groups: altitude (ALT) and control (CON). Both groups spent 22 days at 1300-1800 m. ALT spent 10 h/night for 21 nights in simulated altitude (3000 m), and CON stayed at 1300 m. VO 2max and Hb mass were measured twice before and once after the intervention. Blood was collected for assessment of percent reticulocytes (%retics), serum erythropoietin (EPO), ferritin, and soluble transferrin receptor (sTfR) concentrations. Results: Compared with CON there was an almost certain increase in absolute VO 2max (8.6%, 90% confidence interval 4.8-12.6%) and a likely increase in absolute Hb mass (3.5%; 0.9-6.2%) at postintervention. The %retics were at least very likely higher in ALT than in CON throughout the 21 nights, and sTfR was also very likely higher in the ALT group until day 17. EPO of ALT was likely higher than that of CON on days 1 and 5 at altitude, whereas serum ferritin was likely lower in ALT than CON for most of the intervention. Conclusions: Together the combination of the natural and simulated altitude was a sufficient total dose of hypoxia to increase both Hb mass and VO 2max .
Since the concept of "living high, training low" (LHTL) for enhancement of erythropoiesis and subsequent increase of maximum aerobic power (VO 2max ) was introduced in late 1990s, 1 the effects of using various durations of exposure have been investigated. 2, 3 The less the time of altitude exposure, the more time for training or daily life is provided to athletes, particularly for natural LHTL models where athletes and coaches may have to drive up and down a mountain several times a day. 1 Therefore, reducing the time and days of altitude exposure is now of practical importance to athletes and coaches. To elucidate the lowest "dose-response" threshold, the length of the exposure days, hours per day or night, and the elevation of living and training have been investigated. 4, 5 Other researchers have suggested that if LHTL using simulated altitude is conducted at sea level, the necessary duration is about 3 to 4 weeks and that 12 to 14 hours every 24 hours are required with a simulated altitude of ~2200 to 3000 m. [6] [7] [8] If LHTL is adopted using natural altitude at 1200 m and 2500 m, a similar duration of 3 to 4 weeks is also recommended. 4, 5 Since the magnitude of erythropoietin (EPO) response to hypoxia, which is the primary stimulus for accelerated erythropoiesis, depends on the magnitude of hypoxia, 9 a reduction of days or time of exposure to hypoxia might be possible using more severe hypoxia compared with the recommended level of ~2200 to 2500 m. However, in a previous study, 10 we failed to increase hemoglobin mass (Hb mass ) in runners who completed LHTL for 10 h/night at 3000 m for 30 days at sea level, and a recent blinded study of cyclists also found no increase in Hb mass after ~16 h/night at 3000 m simulated altitude for 28 days. 11 On the other hand, multiple LHTL approaches with continuous stay at a natural altitude >1200 m have found evidence of increased red blood cell production. 1, [12] [13] [14] In this study, we hypothesized that the combination of living and training at 1300 to 1800 m, as well as 10 hours nightly exposure to strong hypoxia of 3000 m simulated altitude for 21 consecutive nights, would be adequate to stimulate enhanced erythropoiesis.
Methods

Subjects
Fourteen male college long-and middle-distance runners who lived in Tokyo (<100 m above sea level) participated in this study. The study was approved by the University of Tokyo Ethics Committee. The subjects gave their written consent to participate in this study (Table 1) .
The subjects were divided into 2 groups: a simulated altitude group (ALT) and a control group (CON). Both groups spent 22 days living and training at ~1300 to 1800 m above sea level (Takayama, Gifu, Japan), and their nightly accommodation was located at 1300 m above sea level. Seven subjects were assigned to ALT, and they spent 10 h/night for 21 consecutive nights in a simulated altitude environment equivalent to 3000 m above sea level. The other 7 subjects were assigned to CON and stayed nightly at the accommodation located at 1300 m above sea level. Both ALT and CON trained at 1300 to 1800 m above sea level. The subjects' training distance and perceived intensity of training during the intervention were recorded and controlled to be similar between the 2 groups (Table 1) . Intensity was self-rated using a Borg Scale 15 : 6 to 11 as low intensity, 12 to 14 as middle intensity, and 15 or greater as high intensity.
Study Design
The prepost CON intervention was 22 days and 21 nights in duration, as shown in Figure 1 . During the preliminary period 2 weeks before the study intervention, all subjects completed VO 2max and Hb mass measurements twice. Postintervention, VO 2max and Hb mass tests were conducted once only due to logistical constraints. Overnight-fasted venous blood samples were collected at days 1, 5, 9, 17, and 21. Throughout the 3-week period of the intervention, all subjects ingested daily 2 sodium ferrous citrate tablets (942 mg of sodium ferrous citrate, Ferromia 50 mg, Eisai, Tokyo, Japan) containing 100 mg of sulfur iron.
VO 2max
The subjects performed a standard warm-up on the treadmill (12-18 km/h) for 20 minutes followed by a 5-minute rest. They then undertook a VO 2max test starting from 18 km/h with 1-km/h increments each minute until reaching 20 km/h. Thereafter, incline increase 1% with each minute until exhaustion. The detailed equipment and procedures of this test have been described previously. 10 
Hb mass
Hb mass was measured using the optimized carbon monoxide (CO) rebreathing method 16 as modified by Gore et al. 17 The dose of CO was 1 mL/kg body mass, and the levels of carboxyhemoglobin in venous blood were measured at least 7 times using a hemoximeter (OSM3, Radiometer, Copenhagen, Denmark). The typical error of measurement for the 2 preintervention Hb mass tests was 19.9 g (90% CI 17.8-40.0 g) or 2.4% for mean Hb mass .
Simulated Altitude
The simulated altitude environment for nightly sleep of ALT was created by filtering compressed air through a highpolymer membrane, controlled to yield a fraction of inspired oxygen (FIO 2 ) of 0.173 (Altitube, YSK, Nara, Japan).
Blood Collection, Hematology, and Biochemistry
All blood samples were collected in the morning after an overnight fast with the subjects in a seated upright position for 10 minutes. The blood was collected in a 2-mL EDTA tubes for whole-blood analysis and a 9-mL serum separator tube for serum analysis. The samples of serum separator tubes were centrifuged (4°C, 10,000 g) for 4 minutes to obtain serum, which was stored at -20°C until batch analysis. Whole blood was analyzed using a fully automated hematology analyzer (XE-2100, Sysmex, Japan) for hematocrit (Hct), hemoglobin concentration (Hb), and percent reticulocytes (%retics). Serum ferritin by chemiluminescent enzyme immunoassay and EPO by RIA2 antibody method were also determined. The remaining serum was stored at -80°C until batch-analyzed for soluble transferrin receptor (sTfR) using an enzymelinked immune assay (ELISA) kit (Human sTfR ELISA, BioVendor Laboratory Medicine, Inc, Czech Republic). The determination range was 0.20 to 10 µg/mL calculated from the absorbance at 405-nm wavelength using a microplate reader (Model 680, Bio-Rad, Tokyo, Japan), as described previously. 18 Samples for sTfR analysis on day 5 could not be obtained due to technical problems. The measurement was made twice for each sample, and the average for each day was used for statistical analysis. Within each day, typical error of the duplicate analyses was 0.10 µg/mL (90% CI 0.07-0.19 µg/mL) or 4.0% for the mean value on preintervention and 1.8% on day 1, 2.7% on day 9, 1.5% on day 17, and 3.3% on day 21.
Statistical Analysis
Raw data were log-transformed before analysis to reduce the effect of heterogeneity or outliers on the outcome measures. Magnitude-based inferences about effect sizes and the precision of estimates were expressed as 90% confidence limits (90% CL). 19 The smallest worthwhile change for a small effect size was 0.2 times the between-subject standard deviation of both groups combined at baseline. The likelihood of the observed differences between groups being larger the smallest worthwhile change were expressed using the following scale: <1%, almost certainly not; 1% to 5%, very unlikely; 5% to 25%, unlikely; 25% to 75%, possibly; 75% to 95%, likely; 95% to 99%, very likely; >99%, almost certainly 20 Differences in the mean change were analyzed using the unequal variances t statistic. Data are expressed as mean and standard deviation, as well as percent change and 90% CL. The individual response was also quantified for Hb mass , VO 2max , and serum EPO. For each, the magnitude of individual responses was calculated from the square root of the difference in the variance of the change scores of the CON and ALT groups. 21 To evaluate the strength of association between 2 variables, linear regression and Pearson coefficient were used.
Results
Training
According to the self-reported training logs (Table 1) , the overall training distance at both 1800-m and 1300-m altitude was not likely different between the ALT and CON groups. The ALT group likely completed more middleintensity but less low-and high-intensity training at 1300 m. There was a 2.1% decrease in body mass in the ALT group and 1.5% decrease in the control group, and the difference between groups from preintervention and postintervention (mean -0.7%; 90% CI -2.1% to 0.8%) was likely trivial.
VO 2max and Hb mass
Compared with the CON group there were an almost certain increase in absolute VO 2max (8.6%; 4.8-12.6%) and a likely increase in absolute Hb mass (3.5%; 0.9-6.2%) between preintervention and postintervention. For both VO 2max and Hb mass , the mean value of the ALT group increased while that of the CON group decreased ( Figure  2 ). The individual variation in VO 2max was 2.8% (90% CI -3.4% to 5.3%), and that for Hb mass was 2.9% (-1.5% to 4.4%). The correlation between change of absolute VO 2max (L/min) and change of absolute Hb mass (g) between preintervention and postintervention was small in both ALT (r = .29, y = 0.0018x -0.12) and CON (r = -.28, y = -0.0024x -0.21) but was moderate for both groups combined (r = .52, y = 0.0044x -0.02; 95% CL of slope -0.0001 to 0.0090).
Hematology and Biochemistry
The change in the Hct of ALT was possibly higher than that of the CON group on day 1 and very likely higher on days 5, 9, 17, and 21. Similarly, the change in Hb concentration of the ALT group was likely higher on days 1, 5, and 17. In addition, the change in %retics was almost certainly higher in ALT than in CON at day 1 and thereafter was very likely or likely higher (Figure 3 ). The change in sTfR was also very likely higher in the ALT group than the CON group until day 17 and was likely higher on day 21. In contrast, serum ferritin was likely lower in ALT than CON on days 5, 9, and 21. The change in EPO of ALT was likely higher than that of CON on days 1 and 5, as well as at day 21. The individual responsiveness of the change in EPO was not as great in the ALT group as in the CON group by a 23% (90% CI -38% to 34%), 27% (-37% to 12%), 23% (-34% to 21%), and 19% (-31 to 23%) on days 1, 9, 17, and 21, respectively, and was 7% (-23% to 33%) greater in the ALT than the CON group on day 5. The correlation between the absolute change in serum EPO and the absolute change Hb mass between preintervention and day 1 was small in both ALT (r = .12) and CON (r = .35) and also for both groups combined (r = .49, y = 1.06, x = 15).
Discussion
The main finding of this study is increased VO 2max and Hb mass after 21 days of just 10 h/night of exposure to simulated altitude and living at 1300 m natural altitude. This is substantially shorter than the 12-to 14-h/d threshold dose commonly recommended to be the minimum necessary to induce an increase in Hb mass and VO 2max , 4,5 although our conclusions must be tempered by the fact that there was moderate interindividual variation of similar magnitude to the mean response.
Dose-Response Threshold for Erythropoiesis With Altitude Exposure
Previous studies using LHTL approaches or simulated altitude at low altitude have investigated various exposure times required to induce an increase of Hb mass . Robach et al 14 reported a 7% increase of Hb mass using simulated altitude of 2500 to 3000 m based at 1200 m natural altitude for 13 days, with nightly exposure to simulated altitude of 16 h/day. Likewise, Wehrlin et al 12 measured a 5% increase of Hb mass after 24 days at 2500 m (18 h/d) and training at 1000 to 1800 m. Compared with these studies, the daily time of our exposure to 3000-m simulated altitude was ~40% shorter, just 10 h/night. But in the current study, staying at ~1300 to 1800 m for the remaining 14 h/d was apparently sufficient to maintain the erythropoietic stimulation 13 as indicated by the likely increased sTfR and %retics throughout the 21 days. Furthermore, the likely lower ferritin of the ALT group than the CON group at most times measured in the current study is also consistent with accelerated erythropoiesis, despite daily supplementation with oral iron.
The documented standard to increase Hb mass is exposure to altitude >2200 m, >12 h/d, >3 weeks, 6 with 1% increase per 100 hours. 7 In the current study the ALT group increased by 2.1% after 210 hours at 3000 m, while the CON group decreased by 1.5%, to yield a net difference between groups of 3.5%. The absolute increase of 2.1% is exactly what would have been predicted on the total hours of exposure for the ALT group. We quantified that the individual responsiveness was 2.9%, which is similar magnitude to the group mean response of 2.1% and even to the 3.5% of the difference between the groups. Robertson et al 22 also quantified that the individual responsiveness for Hb mass was ~2% after 3 weeks of LHTL at 3000 m for 14 h/d. When the group mean effect and the individual response are of similar magnitude it indicates that typically some individuals' Hb mass may not respond at all to LHTL, whereas others may benefit substantially by approximately twice the mean effect.
However, the conclusion of the effect on Hb mass of LHTL has been challenged by a recent double-blind study 11 in which the cyclists, training at 1135 m with 16-h/d exposure to simulated 3000 m altitude for 4 weeks, far exceeded the recommended dose of hypoxia, but there was no measured change of Hb mass . Sampling variation and small true individual responses may have contributed to the result of Siebenmann et al. 11 For instance, in a study from the same key researcher, Nordic skiers trained at 1200 m for 18 days with nightly simulated altitude (2000-3000 m) for 11 h/night (total 198 h at simulated altitude) but did not significantly change Hb mass , 13 although the control group had a 12% decrease, which is surprising. Compared with their control group, the skiers increased Hb mass by 12%. But the lack of an expected 2% increase in Hb mass in the skiers could readily be explained by individual responsiveness and sampling variation.
In contrast to the placebo study, Frese and Friedmann-Bette 23 reported a 5.1% increase in Hb mass after a total of 42 days (20 plus 22 d with an intervening period of 19 d at sea level) at 1300 to 1650 m above sea level. Like the current study, their findings were supported by increases in EPO and sTfR. Their study indicated that staying at even <2000 m altitude with a higher total days of exposure can stimulate erythropoiesis. Based on our results and those of Frese and Friedmann-Bette, 23 further studies of the minimum effective dose of hypoxia appear warranted.
Relationship Between Hb mass and VO 2max
When the data of both the ALT and CON groups were combined, there was a moderate-magnitude correlation coefficient, and the slope of the regression was such that a 100-g increase in Hb mass would yield a 440-mL/min increase in absolute VO 2max . The 95% confidence limits of the slope for this relationship in the current study are relatively wide, so our current result with a small sample size is likely to be serendipitous. Indeed, the magnitude of individual variation of VO 2max (2.8%) was similar to the group mean increase of the ALT group alone (3.9%). So with both VO 2max and Hb mass having small, variable responses it becomes difficult to interpret the slope of this relationship with any confidence. However, from a much more comprehensive series of studies, Schmidt and Prommer 24 concluded that a change in Hb mass of 1 g is associated with a change in VO 2max of approximately 4 mL/min, almost identical to our current result.
It is difficult to explain the decrease in VO 2max and Hb mass of the CON group. Detraining would account for both changes, 25, 26 but with the training relatively closely matched between the ALT and CON groups this suggestion is not supported. None of the CON group subjects reported illness or injury that might have led to a decrease in Hb mass . 27 
EPO Responses and Hematological Changes
EPO of ALT on day 1, which was the first 10 hours after the exposure to simulated altitude, increased by ~110% compared with preintervention. Although the hypoxic stimulus was stronger than in our study, Knaupp et al 28 reported a 50% increase of plasma EPO after just 2 hours of continuous hypoxic exposure (FIO 2 = 0.105). However, we have quantified that the individual responsiveness of the percentage change in EPO from preintervention in the CON group in the current study was ~20% to 25% greater than in the ALT group for 4 of the 5 times EPO was measured at altitude. This result highlights the relatively large day-to-day variation of EPO in normoxia 9,29 but also indicates a relatively consistent increase of EPO in the ALT group ( Figure 3 ) compared with the CON group.
Practical Applications
Our results indicate that against the prevailing paradigm, 4, 5 athletes can use as little as 10 h/night of exposure to simulated altitude (3000 m for 10 h/night for 21 nights) to increase their Hb mass and VO 2max , provided they are living at ~1300 to 1800 m natural altitude. In addition, modest natural altitude of 1300 to 1800 m is logistically simpler to locate than higher altitudes in many countries and, when supplemented with simulated altitude of relatively short duration (10 h/night), allows more opportunity for both training and daily living.
Conclusions
These results indicated that college-level athletes can increase Hb mass about 1% per 100 hours of simulated altitude with as little as 10 h/night exposure to 3000 m for 21 nights, provided that they are living at 1300 to 1800 m natural altitude. However, the individual responses for athletes may have greater scope to increase Hb mass compared with highly trained elite endurance athletes 24 ; our findings require verification on higher-caliber athletes.
